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SUMMARY
This paper describes a stochastic epidemic model developed to infer transmission rates of asymptomatic
communicable pathogens within a hospital ward. Inference is complicated by partial observation of the
epidemic process and dependencies within the data. The epidemic process of nosocomial communicable
pathogens can be partially observed by routine swabs testing for the presence of the pathogen. False-
negative swab results must be accounted for and make it difficult to ascertain the number of patients who
were colonized. Reversible jump Markov chain Monte Carlo methods are used within a Bayesian frame-
work to make inferences about the colonization rates and unknown colonization times. The methods are
applied to routinely collected data concerning methicillin-resistant Staphylococcus Aureus in an intensive
care unit to estimate the effectiveness of isolation on reducing transmission of the bacterium.
Keywords: Bayesian inference; False negatives; Imperfect detectability; Infectious diseases; Markov chain Monte
Carlo methods; MRSA; Reversible jump methods; Screening; Sensitivity; Staphylococcus; Stochastic epidemic
models.
1. INTRODUCTION
The emergence of multidrug-resistant nosocomial pathogens such as methicillin-resistant Staphylococcus
Aureus (MRSA) and vancomycin-resistant enterococci (VRE) has emphasized the importance of trans-
mission prevention within hospitals. Typically, simulation studies, e.g. Se´bille and others (1997), Austin
and others (1999), Lipsitch and others (2000), are used to investigate the effectiveness of widely accepted
infection control procedures. Such studies are limited by the assumptions made about model parameters
and the associated lack of knowledge and uncertainty. In particular, their findings are largely influenced
by assumptions regarding the transmission rate parameters (Cooper and others, 1999).
Estimation of transmission parameters is complicated because the epidemic process can only be par-
tially observed (Becker and Britton, 1999). Nosocomial pathogens are typically carried asymptomatically
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and so the acquisition times are imperfectly observed through infrequent routine swabs. Imperfections
in the observation process are confounded by false-negative swabs. Dependencies within the epidemic
process further complicate the task of transmission parameter estimation. Dependencies arise because the
risk of acquisition depends on the number of others who are colonized.
Jernigan and others (1996) gave transmission rate estimates for isolated and non-isolated patients in a
neonatal intensive care unit (ICU). The analysis required the correct identification of sources and times of
transmissions, which is rarely feasible. Furthermore, it did not consider that different realizations of the
same process could have occurred; that is, it did not consider the element of randomness. In small pop-
ulations such as those in an ICU, significant fluctuations in the incidence and prevalence of colonization
and infection will occur by chance and therefore a stochastic analysis should be undertaken (Bonten and
others, 2001; Renshaw, 1999).
Pelupessy and others (2002) proposed a Markov model to allow for a stochastic analysis of routine
hospital surveillance data. Using maximum likelihood techniques, the transmission rates of VRE colon-
ization were estimated. The model assumed a sequence of surveillance swabs capable of detecting carriage
with certainty. The model formed a basis of the hidden Markov model proposed by Cooper and Lipsitch
(2004) where colonizations were not observed but inferred by the number of patients being infected,
rather than colonized. The underlying Markov model described the number of patients harboring the
organism. The observed number of infections was assumed to follow a Poisson distribution conditional
on the unknown number of patients harboring the organism.
In an earlier paper (Forrester and Pettitt, 2005), an interval-censored approach was used to estimate the
transmission rate of MRSA within an ICU. The number of patients detected with MRSA in a given swab
interval was described as a binomial distribution given the number of patients susceptible to MRSA in
the preceding swab interval. The probability of colonization was described as a function of the number of
non-isolated (colonized) and isolated (colonized) patients in the preceding swab interval. A weakness of
the approach is the inherent assumption that colonizations within each swabbing interval are independent.
Markov chain Monte Carlo (MCMC) methods are currently popular techniques (e.g. Gibson and
Renshaw, 1998, 2001; O’Neill and Roberts, 1999; Streftaris and Gibson, 2004) for analyzing data on par-
tially observed infectious diseases within the community. Unlike the methods proposed by Pelupessy and
others (2002), Cooper and Lipsitch (2004), and Forrester and Pettitt (2005), MCMC methods can be ap-
plied to infer colonization times from interval-censored data leading to greater accuracy and precision in
inference by allowing for dependent transmissions within intervals. The methods appear well suited to
routinely collected hospital data but must be adapted to allow for patient admission and discharge. This
is in contrast to community populations which have relatively small turnover and are typically assumed
to be closed. Cooper (2000) applied this approach to hospital infection data on VRE. The importance of
considering imperfect sensitivity was emphasized but not allowed for in the paper. Swab sensitivity has
been inferred from disease data in non-infectious disease analyses (Smith and Vounatsou, 2003; Trotter
and Gay, 2003).
The objective of this study is to develop methodology to estimate the transmission rate parameters
of a transmissible nosocomial pathogen. MCMC methods are used and adapted for routine surveillance
data and extended to allow for imperfect sensitivity of the surveillance process. We do this by utilizing
reversible jump Markov chain Monte Carlo (RJMCMC) (Green, 1995, 2003). The methodology is ap-
plied to data of the ICU of the Princess Alexandra Hospital (PAH), Brisbane, Australia, to estimate the
transmission rate of MRSA from colonized to non-colonized (susceptible) patients and to quantify the
effect of isolating colonized patients when a background source of MRSA burden exists. Our analysis
suggests that within this ICU, isolation of patients colonized with MRSA is an effective infection control
procedure.
In Section 2, the model and framework for statistical inference are introduced. The MCMC methodol-
ogy is described in Section 3. In Section 4, the methods are applied to data of the PAH ICU.
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The paper concludes with a discussion on limitations of the current model and possible extensions for
future research.
2. MODEL, DATA, AND BAYESIAN FRAMEWORK
2.1 Model
We consider a transient hospital-ward population of patients, some of whom may be asymptomatically col-
onized with a communicable pathogen. Epidemics are initiated by the admission of colonized patients to
the ward or by background contamination. Background contamination is defined to include all nosocomial
transmission arising from outside the ward. Transmissions from colonized health care workers (HCWs),
and from equipment and HCWs transiently contaminated within the hospital but outside the ward, are ex-
amples of possible background contamination sources. Patients admitted in a susceptible (non-colonized)
state can acquire the pathogen by indirect contact with colonized patients via HCWs or by background
transmission. Colonized patients may be detected via routine swabbing procedures and placed in isola-
tion. Susceptible patients can acquire the pathogen via indirect contact with isolated patients; however, it
is expected that the rate will be lower than for non-isolated patients.
The term “importation probability” is used to refer to the probability ϕ that a patient is colonized on
admission to the ward. We assume that the colonization status of patients on admission to the ward is
independent of the colonization status of other patients. The routine swabbing procedure may be subject
to imperfect sensitivity, so that some false-negative swabs are possible. The sensitivity (or detectability)
of the routine swabbing procedure is denoted ρ. We assume 100% specificity.
At a given time t , a ward patient is characterized as being (1) susceptible (but not colonized), (2)
non-isolated (and colonized), (3) isolated from other patients due to being detected as colonized, or (4)
removed or discharged from the ward. Once colonized, patients are assumed to remain so until discharged.
Patients discharged from the ward play no further role in the epidemic. The number of patients in each of
these compartments (susceptible, colonized, isolated, and removed) at time t is denoted S(t), C(t), Q(t),
and R(t), respectively. We use t− to describe a time just prior to time t , so that, for example, S(t−) is the
number of susceptible patients in the ward just prior to time t .
Upon discharge, a patient i will be in one of the following states,
si =
⎧⎪⎨
⎪⎩
ss, if the patient remained susceptible,
sd , if the patient was colonized in the ward,
sp, if the patient was colonized prior to admission.
Assuming homogeneity and no variation in susceptibility or infectivity over time, the probability that
a susceptible patient i is colonized in some small time interval dci > 0, given no colonization up to time
ci , can be described by the hazard function h(ci ), where
h(ci )dci = P(ci < c  ci + dci |c > ci ) = (β0 + β1C(ci ) + β2 Q(ci ))dci + o(dci ). (2.1)
Here β0 is referred to as the background rate, β1 as the non-isolated (colonized) rate, and β2 as the isolated
(colonized) rate. The background transmission rate captures colonizations acquired in the ward that were
not transmitted from a colonized patient in the ward at the time of acquisition. Formulation of the hazard
function in terms of the number of patients is referred to as the “pseudo-mass action” assumption (de Jong
and others, 1995). If the number of transmissions between a colonized patient and each of the susceptible
patients is expected to vary with the number of patients in the ward, β1 and β2 should be divided by the
number of patients in the unit (de Jong and others, 1995).
386 M. L. FORRESTER AND OTHERS
Fig. 1. Stochastic compartmental model. Patients are partitioned as being susceptible, colonized, isolated, or removed.
Admissions, colonizations, isolations, and discharges are events.
Patient admission, colonization, isolation, and discharge times constitute the set of event times (see
Figure 1). We consider that colonizations are stochastic events and that the remaining events are governed
by deterministic dynamics. A variation of the model would allow for stochastic admission, isolation,
and discharge events. The colonization process hazard h(ci ) defined in (2.1) is assumed to be piecewise
constant over each event interval. The variable e is the vector of event times e0  e1  e2 · · ·  eNe
at which the susceptible, colonized, and isolated patient population numbers can change. The described
model is a form of the general stochastic epidemic model (Bailey, 1975; Andersson and Britton, 2000).
A graphical representation is provided in Figure 1.
2.2 Data and notation
The admission, isolation, and discharge times are known for each patient admitted to the ward during
the observation period. Patients in the ward at the beginning of the observation period are assumed to
have been admitted to the ward on that day. If a patient is detected as colonized, the positive swab time
is also known. The colonization time ci is unknown. For a patient i , we let ai , vi , qi , and ri denote,
respectively, the admission, positive swab, isolation, and discharge times. Swabs to test for the presence
of the pathogen are routinely cultured from patients at times ts, where ts = t s1 , t s2 , . . . , t sj , . . . . We assume
that isolates are cultured from all patients in the ward at times ts with 100% compliance. The observed
data {a, v, q, r, ts} are denoted D. The subset Dd = {a, q, r, ts} is given and arises from events which are
not modeled stochastically. The colonization time is censored by the admission time for patients colonized
on admission and by the discharge time for patients remaining susceptible.
2.3 Bayesian framework
Our objective is to make inferences about the parameters; the transmission rates β (see (2.1)), the swab
sensitivity ρ, and the importation probability ϕ, based on the observed data. To do so we explore the joint
posterior density p(β, ρ, ϕ|D). The likelihood p(v|β, ρ, ϕ, Dd) is intractable since it involves integrating
over all possible values of the unknown colonization times. Consequently, we consider the likelihood
of the observed data augmented with both the unobserved colonization times and final patient states,
p(c, s, v|β, ρ, ϕ, Dd).
From Bayes theorem, the posterior density p(β, ρ, ϕ, c, s|D) is proportional to the product of the
parameter likelihood for the observed and augmented data jointly and the parameter prior density, i.e.
p(β, ρ, ϕ, c, s|D) ∝ p(c, s, v|β, ρ, ϕ, Dd)π(β)π(ρ)π(ϕ).
Here π(β), π(ρ), and π(ϕ) are the marginal prior distributions for the parameters β , ρ, and ϕ, respec-
tively, and are assumed independent.
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Joint likelihood of the observed and augmented data. An expression for the likelihood can be obtained
using the Poisson process (Davison, 2003). With perfect sensitivity and no importation events, the like-
lihood is
p(c, s, v|β, Dd) =
∏
si =sd
1max(ai ,t si,v−1)<cimin(vi ,ri )
× exp
⎧⎨
⎩
∑
i :si =ss ,sd
⎛
⎝1si =sd log(β0 + β1C(c−i ) + β2 Q(c−i ))
−
∫ min(ci ,ri )
ai
(β0 + β1C(u) + β2 Q(u))du
⎞
⎠
⎫⎬
⎭ , (2.2)
where 1x is equal to one if x is true and t si,v−1 is the time of last negative routine isolate cultured from
patient i . The first term on the right-hand side (the term involving the indicator function) restricts the
unobserved colonization time according to the admission, last negative swab, positive swab (if a positive
isolate was obtained), and discharge times observed for each patient. The index of the exponential function
sums the log-hazard of each colonization event and the log-survival function for the duration that each
patient remains susceptible, i.e. until colonization or discharge, whichever occurs first.
Imperfect sensitivity changes the likelihood in (2.2) by a factor of ρNTP(1 − ρ)NFN(c,D), where NFN
(c, D) and NTP are the numbers of false-negative and true-positive swabs, respectively. In the application
that follows we do not have, and therefore do not assume, information on swabs cultured from patients
after the first positive isolate. Without this information, an informative prior distribution is required for
the swab sensitivity parameter ρ. We must also account for the possibility of patients being colonized on
admission. The likelihood of the set of importation events is ϕNsp (s)(1 − ϕ)NA−Nsp (s) where Nsp (s) is the
number of patients colonized on admission and NA is the number of admissions to the ward during the
observation period.
Adapting (2.2) for imperfect detectability and the set of importation events, the likelihood of the joint
data is
p(c, s, v|β, ρ, ϕ, Dd) =
∏
si =sd
1ai <cimin(vi ,ri )ρ
NTP(1 − ρ)NFN(c,D)ϕNsp (s)(1 − ϕ)NA−Nsp (s)
× exp
⎧⎨
⎩
∑
i :si =ss ,sd
⎡
⎣1si =sd log(β0 + β1C(c−i ) + β2 Q(c−i ))
−
∫ min(c−i ,r−i )
ai
(β0 + β1C(u) + β2 Q(u))du
⎤
⎦
⎫⎬
⎭ . (2.3)
To compare (2.3) with (2.2), the first term involving the indicator function now allows the unobserved
colonization time ci to take place any time immediately after admission and before the sooner of the pos-
itive swab or discharge time. The next set of terms involving ρ and ϕ give the probabilities, as explained
earlier, for imperfect sensitivity and colonization on admission. The exponential terms remain unchanged
from (2.2).
The transmission rates are constrained to be greater than zero. If, for example, we wanted to allow
for a null background transmission rate, that is β0 = 0, we would have to multiply (2.3) by ∏i :si =sd
1C(c−i )+Q(c−i )>0. With a null background transmission rate, there must be at least one colonized or isolated
patient in the ward for another patient to be colonized in the ward.
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Prior distributions. We assume proper uniform priors for the transmission rate parameters and beta priors
for the sensitivity and importation probability parameters.
3. MCMC ALGORITHM AND CONVERGENCE ASSESSMENT
3.1 MCMC algorithm
MCMC is used to approximate the posterior p(β, ρ, ϕ, c, s|D) by iteratively drawing samples of (β, ρ,
ϕ, c, s) values. Metropolis (Metropolis and others, 1953) update steps are used for the transmission rate
parameters and Gibbs (Geman and Geman, 1984; Gelfand and Smith, 1990) update steps for the swab
sensitivity and importation probability parameters. The final patient state and colonization time for each
admission are updated jointly according to Metropolis–Hastings (Metropolis and others, 1953; Hastings,
1970). The update step for the final patient state and colonization time may require RJMCMC, depending
on the current and proposed final state.
To generate the Markov chain β [2]k , β
[3]
k , . . . , β
[g]
k , . . . , for each of the transmission rates βk where
k ∈ {0, 1, 2}, given some current value β [g]k , we first propose a new value βk . The value is set to the
absolute value of a random number generated from a Gaussian density centered on β[g]k . The proposed
transmission rate, βk , is accepted with probability
α(βk |β, c, D) = min
(
1,
p(βk |β−k, c, D)
p(β[g]k |β−k, c, D)
)
as the proposal density is symmetric. Here p(βk |β−k, c, D) is the full conditional of βk , which is propor-
tional to
exp
⎧⎨
⎩
∑
i :si =sd
(log(β0 + β1C(c−i ) + β2 Q(c−i ))) − β0
eNe −1∑
j=1
S(e j )(e j+1 − e j )
⎫⎬
⎭π(β0),
exp
⎧⎨
⎩
∑
i :si =sd
(log(β0 + β1C(c−i ) + β2 Q(c−i ))) − β1
eNe −1∑
j=1
S(e j )C(e j )(e j+1 − e j )
⎫⎬
⎭π(β1),
and
exp
⎧⎨
⎩
∑
i :si =sd
(log(β0 + β1C(c−i ) + β2 Q(c−i ))) − β2
eNe −1∑
j=1
S(e j )Q(e j )(e j+1 − e j )
⎫⎬
⎭π(β2)
for k = 0, 1, and 2, respectively.
To generate a Markov chain for the swab sensitivity and importation probability, values are sampled
from their full conditional distributions,
p(ρ|β, ϕ, c, s, D) ∝ Beta(NTP + zaρ, NFN(c, D) + zbρ) and
p(ϕ|β, ρ, c, s, D) ∝ Beta
(
Nsp (s) + zaϕ, NA − Nsp (s) + zbϕ
)
, respectively.
The colonization time and final state are updated concurrently for each patient. To do so, a patient i
is chosen at random and one of several proposals is made dependent on whether a positive isolate was
obtained from that patient during his/her stay in the ward. This step is repeated for a given fraction of
admissions, sampled at random, to the ward during the observation period.
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Following Green (1995, 2003), we label each possible proposal and consider that certain proposals (or
moves) occur in pairs. A pair consists of a move from one state to another and a move in reverse. Figure 2
illustrates possible moves depending on the current patient state and defines the proposal probabilities and
the corresponding reverse moves.
Proposing to change a patient’s final state from colonized in the ward (sd ) to either never colonized
(ss) or colonized prior to admission (sp) and vice versa requires either the proposal of a colonization time
or the removal of the currently assumed colonization time for that patient. Evaluation of proposals within
these move pairs requires comparisons between realizations of the process with different numbers of col-
onization events. As the colonization times are model parameters and the number of colonization times is
unknown, we require a framework for jumping between parameter subspaces of differing dimensionality.
We employ RJMCMC to move between the different dimensional spaces.
When changing patient i’s final state from si to some state si , we can show using the ideas of Green
(1995, 2003) that detailed balance will be preserved if the new state is accepted with probability
αsi si = min
{
1,
p(ci , s

i |β, ρ, ϕ, c−i , s−i , D) jm(si |si )qsi (ci |D)
p(ci , si |β, ρ, ϕ, c−i , s−i , D) jm(si |si )qsi (ci |D)
∣∣∣∣∂(ci )∂(ci )
∣∣∣∣
}
. (3.1)
A description of p(ci , s

i |β, ρ, ϕ, c−i , s−i , D), the target distribution; jm(si |si ), the state proposal proba-
bility; and qsi (c

i |D), the parameter proposal density is given below. The Jacobian
∣∣ ∂(ci )
∂(ci )
∣∣ is equal to one
in all instances and not discussed further.
Target distribution p(ci , si |β, ρ, ϕ, c−i , s−i , D). The target distribution is the full conditional of the
proposed state si and associated censored colonization time c

i for the selected patient i . It is proportional
to the joint posterior,
p(ci , s

i |β, ρ, ϕ, c−i, s−i, D) ∝
[ ∏
si =sd
1ai <cimin(vi ,ri )
]
(1 − ρ)NFN(ci ,D)ϕ1si =sp (1 − ϕ)1si =sp
× exp
⎧⎪⎪⎨
⎪⎪⎩
∑
a:sa=sd
cicari
(log(β0 + β1C(c−a ) + β2 Q(c−a )))
−
∑
j :aie j <ci
S(e j )(β0 + β1C(e j ) + β2 Q(e j ))(e j+1 − e j )
⎫⎬
⎭ . (3.2)
Note that if si = sp, then the summations in the braces are not required.
Fig. 2. Possible Markov chain moves to update patient state. Given 100% specificity move types
(iv), (iv)′, (v), (v)′, (vi), and (vi)′ are not possible for detected patients.
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State proposal probability, jm(s|s). The state proposal probability is the probability of proposing to
update the selected patient’s state from si to si . The probabilities are defined in terms of the parameters
K1, K4, K5, K ′1, K ′4, and K ′5 introduced in Figure 2. For example, the state proposal probability for move
type (i), j(i)(sp|sd), is K1.
Parameter proposal density, qsi (c

i |D). The parameter proposal density is the probability density of
proposing a given colonization time. Proposing a final state of susceptible (ss), or colonized prior to
admission (sp), is equivalent to proposing no colonization event during a patient’s stay in the ward. If a
final state of colonized in the ward (sd ) is proposed, a colonization time ci is proposed from an exponential
distribution truncated at the patient’s admission time.
3.2 Convergence assessment
Cowles and Carlin (1996) review a number of approaches to assess MCMC convergence. We define a set
of realizations according to the number of patients inferred (rather than observed) to have been colonized
in the ward. Convergence of the transmission rate, sensitivity, and importation probability parameters in
addition to the number of realizations can be ascertained using the convergence diagnostics proposed by
Geweke (1992) and Gelman and Rubin (1992). These approaches will not detect lack of convergence
within each realization. This problem is overcome by the method of Brooks and Giudici (1998). Like
the method proposed by Gelman and Rubin (1992), Brooks and Giudici (1998) propose running parallel
chains and splitting the total variation not only between chains but also between models or realizations.
A weakness of the approach is that the last two sources of variation are unstable if a rare model (i.e. number
of patients inferred) is visited by one of the chains. An alternative approach has been proposed by Castelloe
and Zimmerman (2002) in which visits to rare models have a lesser impact on the convergence diagnostics.
The convergence diagnostic utilizes multiple chains and detects between-chain variation, between-model
variation that differs from one chain to another, and significant differences in the frequencies of model
visits from one chain to another.
4. APPLICATION: MRSA TRANSMISSION WITHIN THE PAH ICU
We consider a data set (previously analyzed by Forrester and Pettitt, 2005) of routinely collected in-
formation concerning admissions and MRSA occurrence of the PAH ICU between 1 January 1995 and
28 March 1997. Table 1 and Figure 3 summarize key characteristics of the data. During this period, the
ICU had 12 beds: 2 isolation rooms, 2 × 2-bed bays, and 2 × 3-bed bays.
For each admission i to the ICU, the date and time of admission and discharge were recorded. The
data concerning MRSA colonization outcome were collected from routine nasal or groin swabs. The swabs
were taken on mondays and thursdays. We assume they were taken at 11 AM with 100% compliance. For
patients notified as MRSA positive, the positive swab time (vi ) and the notification time (qi ) (assumed to
occur at 11 AM on the recorded date) were recorded. For some patients, the date of the swab returning
a positive isolate was either not recorded or listed as occurring after notification of the swab outcome.
In case of discrepancy, the swab date resulting in a positive isolate is set to be 2 weekdays prior to the
notification date.
Upon notification of a patient being colonized with MRSA, the patient was placed in isolation. When
there were three or more detected MRSA patients, they were grouped in a two- or three-bed bay and
referred to as cohorted. We consider that detected patients were isolated as soon as notification was re-
ceived, regardless of the delay between notification and isolation and whether the patient was placed in
isolation or cohorted. In contrast to the general ward, the isolation room had a sink for each patient bed
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Table 1. Key characteristics of data
Data Value
Number of beds in ICU (mean occupancy) 12 (9)
Duration of study period, days 818
Number of swab intervals, Nint 233
Number of admissions 2588
Number of positive isolate notifications 121
Number of positive isolates taken in ICU 108
Number of admissions with first swab positive 46
Mean prevalence of detected patients, % 14
Mean length of stay of detected patients, days 13
Mean length of stay of non-detected patients, days 2
Mean number of swabs per patient 0.78
Mean number of detected patients in ICU, per day 1.31
Fig. 3. Number of beds occupied, positive isolates cultured from patients per swab day, and the number of detected
MRSA patients in the ICU during the observation period.
and the hand-washing policy was signposted at the entrance to the room. Each sink had dispensers for
gloves, soap, antibacterial scrub solution (chlorhexidine or iodophor), and skin moisturiser. All HCWs
and visitors to the isolation room were required to wear gowns. Only the allocated nurse or nominated
relief staff would contact the isolated or cohorted patient.
We fitted the described model to the PAH ICU data with uniform Unif(0, 1] priors for the transmission
rates, an informative Beta(127.2, 31.8) (mean 0.8, variance 0.001) prior for the sensitivity parameter, and
an uninformative Beta(1, 1) prior for the importation probability parameter. A discussion concerning the
choice of these priors is left to Section 5.
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4.1 Posterior summaries
To make inference, 380 000 MCMC iterates were used following a burn-in of 20 000 iterates. The 380 000
iterations were then thinned by a factor of 40, leaving 9500 iterations for inference. In each iteration,
the colonization times were updated for 10% of admissions during the observation period, with each ad-
mission chosen at random. Probabilities (K1, K4, K5, K ′1, K ′4, K ′5) of the allowable proposal states given
the current patient state were weighted equally. The transmission rates are measured in terms of new
colonizations per day.
The observed and augmented data for July 1995 taken from one iteration of the Markov chain are
shown in Figure 4. Table 2 and Figure 5 present the estimated transmission rate, sensitivity, and importa-
tion probability parameters, in addition to estimates of the number of acquired and imported MRSA cases.
The 95% credible interval for the difference in transmission between non-isolated and isolated patients,
β1 − β2, includes the value zero. The posterior mean sensitivity of the swabbing process is lower than the
prior mean. It is estimated that 46.0% [95% credible interval 36.0,61.7] of MRSA patients were detected
and 45.5% [95% credible interval 41.3,48.7] of MRSA cases were imported. A strong negative posterior
correlation was found between the non-isolated (β1) and background (β0) transmission rates (−0.57).
Fig. 4. MRSA transmission in the PAH ICU. The graph includes the observed and augmented data of one iteration
of the Markov chain for patients in the ICU during the period 16 July 1995 to 23 July 1995. Each horizontal bar
represents one admission. The Markov chain imputes the duration of colonization (and whether by importation or
transmission) preceding patient discharge or detection. the number of false-negative swabs that would have been
cultured from the patient in this Markov chain iteration are given on the right-hand side of the graph.
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Table 2. Summary statistics of the marginal posterior distributions for model parameters and imputed
numbers of colonization events
Parameter Mean Standard Markov chain 2.5% Median 97.5%
deviation error of mean
Background β0 0.0103 0.0039 7.7 × 10−05 0.0033 0.0101 0.0186
Non-isolated β1 0.0131 0.0051 1.1 × 10−04 0.0038 0.013 0.0236
Isolated β2 0.0045 0.003 4.0 × 10−05 0.0003 0.0041 0.0113
β1 − β2 0.0086 0.0063 1.3 × 10−04 −0.0035 0.0086 0.0209
Sensitivity ρ, % 71.7 3.8 6.5 × 10−02 64.1 71.7 78.9
Importation Prob ϕ, % 4.7 0.9 2.0 × 10−02 3.0 4.6 6.7
No. colonized in ICU 143.1 14.8 2.4 × 10−01 115 143 173
No. colonized on admission 119.7 21.6 5.0 × 10−01 81 119 164
Fig. 5. Posterior densities of model parameters and posterior distributions of imputed numbers of colonization events.
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Background transmission (β0) was weakly correlated with both isolated transmission (β2) (−0.32) and
the importation probability (ϕ) (−0.23).
Convergence was verified using the Geweke (1992) and Gelman and Rubin (1992) convergence
diagnostics provided within CODA (Version 0.40bs1, MRC Biostatistics Unit, Cambridge, United
Kingdom). The Castelloe and Zimmerman (2002) convergence diagnostics were used to verify within-
model convergence.
4.2 Model assessment
Goodness of fit. The posterior predictive assessment method (Rubin, 1984; Gelman and others, 1996,
2000) compares observed Dobs and replicated Drep data sets on the basis of test statistics T (D) and test
discrepancies T (D, θ). The algorithm is to construct a replicated data set for each draw from the posterior
distribution, evaluate the test statistic or discrepancy for the drawn parameter values and each of the data
sets, real and replicated, and produce a scatter plot with the discrepancy of the observed data on the x-axis
and the discrepancy of the replicated data on the y-axis. If the model fits, replicated data generated under
the model should look similar to observed data. The predictive p-value is the proportion of times the
predictive discrepancy D(Drep; θ ) is greater than or equal to the observed discrepancy D(Dobs; θ ), or the
proportion of points in the scatter plot which lie above the line of unit slope. A p-value of 0.5 is optimal.
We use posterior prediction to compare the number of detected patients during the observation period in
the observed and simulated data sets (see Figure 6).
The cross-validation technique (Gelfand and others, 1992) uses existing data, rather than hypotheti-
cal realizations, to validate the model. It compares the observed responses y j to those expected, Y j |y− j ,
from the data y− j with the j th response missing. Various checking functions are possible. We use the
Freeman–Tukey residual and the tail-area probability. The Freeman–Tukey residuals, √y j −
√
E(y j |y−j),
are appropriate when counts are small (Brooks and others, 2000). In practice, the residuals can be
Fig. 6. Histogram of 1000 simulations for T (Drep), the test statistic for the total number of patients detected, using
the posterior predictive distribution. The vertical line represents T (Dobs) = 121.
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approximated,
d j ≈ y j − 1G
G∑
g=1
E(y j |θ [g]). (4.1)
Unless the data set is small and y j is an extreme outlier, this approximation should be adequate
(Carlin and Louis, 2000). Plotting the residuals d j against the swab times t j should reveal patterns of over-
/underfitting. The residuals should be approximately normal with large absolute values causing concern.
The tail-area probabilities of the response, d ′j = P(Y j < y j |y− j ), should be uniformly distributed.
The observed number of detected patients y j per swab interval can be derived directly from the data
and is straightforward to calculate. The expected number of detected patients per swab interval for a given
Markov chain iteration g is considered to be binomially distributed,
y[g]j ∼ Bin(n[g]j , ρ[g]),
where n[g]j is the number of colonized patients swabbed in the j th swab interval. The posterior expectation
of this value is approximated by
E(y j |y− j ) ≈ 1G
G∑
g=1
n
[g]
j ρ
[g]
.
These values are substituted into (4.1) to obtain the Freeman–Tukey residuals. The lower and upper tail-
area probabilities are
Pl = P(Y j  y j |y− j ) ≈ 1G
G∑
g=1
y j∑
i=0
(
n
[g]
j
i
)
ρ[g]i (1 − ρ[g])(n[g]j −i)
and
Pu = P(Y j  y j |y− j ) ≈ 1G
G∑
g=1
n
[g]
j∑
i=y j
(
n
[g]
j
i
)
ρ[g]i (1 − ρ[g])(n[g]j −i),
respectively. The two-sided tail-area probability is obtained by selecting twice the minimum of the lower
and upper values. The Freeman–Tukey residuals and tail-area probabilities are provided in Figure 7.
The distribution of the expected detection outcome is concentrated around the observed detection value
somewhat more than expected. Overall, there do not appear to be any unusually poorly fitted cases or
time trends suggesting lack of fit. If hypothesized true parameter values were used with continuous data,
we would expect the tail-area probabilities to have a (0, 0.5) uniform distribution. With discrete data, the
two-sided tail-area probabilities are distributed over an interval (0, a), a ∈ (0.5, 1]. For a unimodal distri-
bution with a large modal probability close to one, a itself is close to one corresponding to observing the
modal value. The distribution of the two-sided tail-area probabilities for the data is highly skewed toward
one suggesting a reasonable fit.
Alternative methods to assess goodness of fit include conditional Bayesian p-values (Bayarri and
Berger, 1998), posteriors from the simulation (Dey and others, 1995; Sinha and Dey, 1997), Bayesian
latent residuals (Aslanidou and others, 1998; Ibrahim and others, 2001), and prequential (Arjas and
Gasbarra, 1997; Ibrahim and others, 2001) approaches but we have not investigated these further.
Impact of prior information. An informative Beta(127.2, 31.8) (mean 0.8, variance 0.001) prior distri-
bution was used for the sensitivity parameter. We assess the impact on the posterior distributions when
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Fig. 7. Checking functions for the number of detected patients using the cross-validation approach. The first plot
illustrates the observed and expected number of detected patients at each swab time. The second plot shows the
Freeman–Tukey residuals d j at each swab time. The third plot is the density of tail-area probabilities.
Table 3. Estimated absolute risk per day of non-isolation for each different prior for the sensitivity
parameter
Prior for sensitivity, ρ Mean Standard 2.5% Median 97.5%
deviation
Uniform(0.6,1) 0.0103 0.0067 −0.0033 0.0105 0.0229
Beta, mean 0.6, var 0.001 0.0116 0.0069 −0.0026 0.0119 0.0243
Beta, mean 0.7, var 0.001 0.01 0.0066 −0.0035 0.0101 0.0226
Beta, mean 0.8, var 0.001 0.0086 0.0063 −0.0035 0.0086 0.0209
Beta, mean 0.9, var 0.001 0.008 0.006 −0.0035 0.008 0.0196
Beta(146.3, 62.7) (mean 0.7, variance 0.001), Beta(80.1, 8.9) (mean 0.9, variance 0.001), and Unif(0.6, 1)
prior distributions are used. These prior distributions have been chosen to reflect information about the
sensitivity of the swabbing process (see Section 5).
The posterior mean value of the estimated decrease in transmission per day by isolating a colonized
patient is provided in Table 3 for various informative sensitivity (ρ) priors. A higher prior mean for the
sensitivity will lead to a lower estimated non-isolated transmission (β1) rate. The isolated transmission
(β2) rate remains more or less the same regardless of the prior mean. The estimated decrease in mean
transmission resulting from isolation, (β1−β2), is smaller for higher prior sensitivity means. These results
are understandable because the number of patients colonized in the ward, C(t), must increase as the
assumed sensitivity, ρ, decreases. For β1C(t) to remain constant, β1 must decrease as C(t) increases.
Additional colonizations due to the sensitivity decreasing are explained by β0 increasing. The number
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of patients isolated is known and so β2 Q(t) remains constant. We stress that conclusions concerning the
effectiveness of isolation are dependent on what is assumed about the imperfect sensitivity.
5. DISCUSSION
We have considered a model for the analysis of communicable hospital pathogens using routinely col-
lected surveillance data. The methodology is applicable to pathogens which conform to the susceptible-
colonized-removed paradigm. The algorithm permits inference about nosocomial transmission and
importation probability even when the surveillance data are subject to false-negative results.
The methods are applied to MRSA data from the ICU in the PAH. MRSA transmission is primarily via
transiently contaminated HCWs. The role of HCWs as vectors of transmission is implicit and not modeled
explicitly.
An MCMC approach within a Bayesian framework is used to determine posterior distributions of
transmission rates from background, non-isolated colonized patient, and isolated (colonized) patient sour-
ces, in addition to detection sensitivity and the probability of being colonized on admission. For all pa-
rameters excluding the detection sensitivity, non-informative priors were chosen.
The prior distribution for the detection sensitivity was chosen to reflect current information concerning
the probability that a patient colonized with MRSA is detected at a routine swabbing time. This value is
likely to depend on the number and location of patient swabs, compliance to swabbing and laboratory
procedures. Routine swabs taken at the PAH ICU are taken from the nares or groin and will not detect
throat or perineum colonization. One study (Coello and others, 1994) found that 9.9% of carriers in
a university hospital were colonized in the perineum alone and 5% in the throat alone. Compliance to
swabbing within the PAH ICU during the observation period is unknown; however, an unpublished report
suggests it was approximately 93% in 1993. Sensitivity of laboratory methods for detecting MRSA was
66.7% [95%CI 51.9,83.3] in one study (Hope and others, 2004) and 81% for detecting S. aureus nasal
colonization and 87% for detecting S. aureus tracheal colonization in another study (Keene and others,
2005).
The likelihood of the data has a strong effect on the sensitivity parameter giving high posterior values
to small values of the sensitivity parameter. With a posterior mean sensitivity of 71.7% (95% credible
interval 64.1,79.0), the mean rate of transmission of MRSA from isolated patients was lower (0.0045
transmissions per day) than the mean rate from non-isolated patients (0.0131 transmissions per day).
The posterior mean absolute risk of non-isolation (0.0086 transmissions per day, 95% credible inter-
val −0.0035, 0.0209) is higher than that estimated by Forrester and Pettitt (2005) using the same data.
Forrester and Pettitt (2005) estimated that the absolute risk of non-isolation was 0.0036 transmissions per
day (95% credible interval −0.0011, 0.0086), whereas the model assumed independence of colonizations
within the same swabbing interval and 100% sensitivity. A higher estimate for the absolute risk of non-
isolation (0.131 transmissions per day) was obtained during an epidemic outbreak within a neonatal ICU
(Jernigan and others, 1996). Our model is applied to endemic data in which background transmission can
take place when no colonized patient is present. The background transmission rate was found to be 0.0103
transmissions per day.
The estimated mean importation probability (4.7%, 95% credible interval 3.0,6.7) is supported by the
literature. Published rates for the proportion of patients colonized with MRSA on admission include 6.8%
for an Australian ICU (Marshall and others, 2003), 6.9% (range 3.7 to 20%) among 14 French ICUs
(Lucet and others, 2003), and 10% for an English ICU (Thompson, 2004). More recent studies (Troche´
and others, 2005; Eveillard and others, 2005) in France detected colonization on admission rates varying
from 4.2 to 10.1%.
The MCMC methodology employed here facilitated the imputation of the unobserved colonization
times of patients admitted to a hospital ward. Non-aggregated patient-level data were used thereby
398 M. L. FORRESTER AND OTHERS
exploiting the full information content of the data. The framework can be readily extended to allow for
heterogeneity in susceptibility. By introducing a latent parameter to identify the source of infection for
each infected individual, MCMC sampling on the transmission rate parameters can be performed using
Gibbs steps (Geman and Geman, 1984; Gelfand and Smith, 1990) rather than Metropolis–Hastings steps
(Metropolis and others, 1953; Hastings, 1970).
Transmission from a colonized or isolated patient was assumed to remain constant until discharge.
This assumption can be investigated statistically by modeling the hazard as being dependent on the colo-
nization time of the patient.
We did not have data on compliance during the period of observation (1995 to 1997); 100% compli-
ance was assumed. With less than perfect compliance, the number of swabs taken would be lower than
calculated and it is reasonable to expect that the true sensitivity value may be higher than estimated by the
model.
A recent review (Cooper and others, 2003) highlighted a pressing need for research to determine the
effect of isolation wards in hospitals. We have presented an approach which allows the effect on isolation
in hospital wards to be quantified. When applied to data from the PAH ICU, we found that the transmission
rate from isolated patients is lower than from non-isolated patients. In prospective studies, it is clear that
detectability will have a critical role in determining the transmission rates for patients in isolation.
Findings from the presented approach will be advantageous to simulation studies requiring knowl-
edge of the transmission rate parameters, for which there is a lack of information. Additionally, analysis
of simulated data using the methods described here could assist in the design of future studies, e.g. to
determine the ideal study duration and swab frequency. The methodology presented here can be used to
quantify the effect of infection control interventions by providing pre- and post-intervention estimates of
key transmission parameters. Evidence-based decisions can therefore be made on the impact of infection
control procedures.
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